FDA Drug Recalls

Recalls / Firms / Viatris Inc

Viatris Inc

22 FDA drug recalls on record1 Class I.

DateClassDrugStatus
2024-12-23Class IICarduraTerminated
2024-12-23Class IICarduraTerminated
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-11-18Class IILevothyroxine SodiumOngoing
2024-04-30Class IICardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in SiCompleted
2024-04-30Class IICardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in SinCompleted
2024-04-25Class IIIValacyclovir HydrochlorideCompleted
2023-05-25Class IILevsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for InjectioTerminated
2022-10-21Class IICarvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals IncTerminated
2022-10-07Class IOctreotide AcetateTerminated
2022-09-21Class IIAmpicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials pTerminated
2022-04-28Class IIXanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, DistributeTerminated
2022-04-28Class IIAlprazolamTerminated